The target product profile sheet (TTP) is a commonly used tool in the biopharmaceutical industry that assists in the strategic decision-making process. It’s designed to help you decide whether to advance a product candidate or drug program. While the TTP is not comprehensive in nature, it focuses on the key elements necessary to make “go, no go” decisions. This session will review a standard TTP and the assumptions underlying the key elements that go into creating a TTP.
Speaker: Drs Fred Mermelstein MD & Carl Novina MD PhD
About the Speakers:
Dr. Fred Mermelstein, Founder of several start-ups, Entrepreneur-in-Residence at Dana-Farber Cancer Institute and Lecturer in Department of Neurobiology, Harvard Medical School, will lecture on the three critical elements that drive product development success, specifically: unmet medical need, reimbursment, and intellectual property. In this workshop, your company will evaluate its own technology and the Harvard Biotechnology Incubator [“HBI”] team will provide immediate feedback as part of the session. Drs. Fred Mermelstein and Carl Novina, Principal Investigator at Dana-Farber Cancer Institute and Harvard Medical School, co-edited a Biotechnology textbook entitled, “Biotechnology, From Idea to Market”, and serve as mentors to the Harvard Biotechnology Incubator (HBI). Fred & Carl are also cofounders of the Life Lab resident biotech startup company SanaRx, which was conceived through the efforts of the innovative HBI program.
This session is targeted to Health & Life Sciences ventures teams in the i-lab’s Venture Program. For team leads in the i-lab Venture Program, it’s best to register through the i-lab portal here or through the program calendar. Otherwise you can register below.